English
Home > Products > CAS NO 62893-19-0

China CAS NO 62893-19-0 Factory

Our business sticks for the basic principle of "Quality could be the life with the firm, and track record will be the soul of it" for CAS NO 62893-19-0,62893-19-0,Cefoperazone intermediate,Cefoperazone advance intermediate,Cefoperazone Acid, Only for accomplish the good-quality solution to meet customer's demand, all of our products and solutions have been strictly inspected before shipment.
CAS NO 62893-19-0, With good quality, reasonable price and sincere service, we enjoy a good reputation. Items are exported to South America, Australia, Southeast Asia and so on. Warmly welcome customers at home and abroad to cooperate with us for the brilliant future.

Related Products

Hot Products

  • Copper(II) gluconate

    Copper(II) gluconate

    Product Name:Copper(II) gluconate
    Molecular Formula:C12H22CuO14
    Molecular Weight:453.84
    CAS Registry Number:527-09-3
  • 3-Pyridinesulfonyl Chloride

    3-Pyridinesulfonyl Chloride

    Product ​Name:3-Pyridinesulfonyl chloride Molecular Weight:177.61 CAS NO:16133-25-8 Usage:Vonoprazan Intermediates
  • Triethylsilane

    Triethylsilane

    Product Name:Triethylsilane
    Molecular Formula:C6H16Si
    Molecular Weight:116.28
    CAS Registry Number:617-86-7
  • Abiraterone acetate

    Abiraterone acetate

    Product Name:Abiraterone acetate
    Molecular Formula:C26H33NO2
    Molecular Weight;391.55
    CAS Registry Number;154229-18-2
  • SAMARIUM

    SAMARIUM

    Product Name:SAMARIUM
    Molecular Formula:Sm
    Molecular Weight:150.36
    CAS Registry Number:7440-19-9
  • Ramatroban

    Ramatroban

    Product Name:Ramatroban
    Molecular Formula:C21H21FN2O4S
    Molecular Weight;416.47
    CAS Registry Number;116649-85-5
  • Related Blog
  • Reviews

  • CAS 148553-50-8 What is Pregabalin?

    Pregabalin is an anti-epileptic drug, also called an anticonvulsant. It works by slowing down impulses within the brain that cause seizures. Pregabalin also affects chemicals within the brain that send pain signals across the systema nervosum.

  • What is an Active Pharmaceutical Ingredient (API in Pharma)?

    Sandoo Pharmaceutical is a professional active pharmaceutical intermediate manufacturer, producing high quality APIs. Sandoo Pharmaceutical provides a wide range of active pharmaceutical intermediates.

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept